Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: A ‘class effect’ of TNF-α antagonists or simply an anti-psoriatic treatment adverse reaction?

By Rallis Efstathios   Korfitis Chrysovalantis   Stavropoulou Evgenia   Papaconstantis Markos  

Journal of Dermatological Treatment, Vol. 21, Iss. 1, 2010-01 ,pp. : 3-5

Informa Healthcare

Access to resources Recommend Favorite

The effect of topical corticosteroids in combination with alefacept on circulating T-cell subsets in psoriasis

By Langewouters Annechien   Bovenschen Jorn   De jong Elke   Van Erp Piet   Van De Kerkhof Peter  

Journal of Dermatological Treatment, Vol. 18, Iss. 5, 2007-01 ,pp. : 279-285

Informa Healthcare

Access to resources Recommend Favorite

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting

By Bonafede Machaon   Johnson Barbara H.   Fox Kathleen M.   Watson Crystal   Gandra Shravanthi R.  

Journal of Dermatological Treatment, Vol. 24, Iss. 5, 2013-10 ,pp. : 369-373

Informa Healthcare

Access to resources Recommend Favorite

Immunological and Clinical Effects of Alphacalcidol in Patients with Psoriatic Arthropathy: Results of an Open, Follow-up Pilot Study

By Gaál János   Lakos Gabriella   Szodoray Péter   Kiss Judit   Horváth Irén   Horkay Edit   Nagy Georgina   Szegedi Andrea  

Acta Dermato-Venereologica, Vol. 89, Iss. 2, 2009-03 ,pp. : 140-144

Medical Journals Limited

Access to resources Recommend Favorite

Molecular Markers Associated with Clinical Response to Bexarotene Therapy in Cutaneous T-cell Lymphoma

By Ranki Annamari   Väkevä Liisa   Sipilä Laura   Krohn Kai  

Acta Dermato-Venereologica, Vol. 91, Iss. 5, 2011-09 ,pp. : 568-573

Medical Journals Limited

Access to resources Recommend Favorite